PL352992A1 - Sposób otrzymywania podstawionych pochodnych cyklopentanu i nowe krystaliczne struktury pochodnych cyklopentanu - Google Patents

Sposób otrzymywania podstawionych pochodnych cyklopentanu i nowe krystaliczne struktury pochodnych cyklopentanu

Info

Publication number
PL352992A1
PL352992A1 PL00352992A PL35299200A PL352992A1 PL 352992 A1 PL352992 A1 PL 352992A1 PL 00352992 A PL00352992 A PL 00352992A PL 35299200 A PL35299200 A PL 35299200A PL 352992 A1 PL352992 A1 PL 352992A1
Authority
PL
Poland
Prior art keywords
crystalline structures
novel crystalline
preparing substituted
substituted cyclopentane
cyclopentane derivatives
Prior art date
Application number
PL00352992A
Other languages
English (en)
Other versions
PL213231B1 (pl
Inventor
Ahmed F. Abdel-Magid
Hans-Ulrich Bichsel
Daniel J. Korey
Gunther G. Laufer
Erja A. Lehto
Sebastiano Mattei
Max Rey
Thomas W. Schultz
Cynthia Maryanoff
Original Assignee
Biocryst Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharmaceuticals, Inc. filed Critical Biocryst Pharmaceuticals, Inc.
Publication of PL352992A1 publication Critical patent/PL352992A1/pl
Publication of PL213231B1 publication Critical patent/PL213231B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL352992A 1999-06-28 2000-06-09 Sposób otrzymywania zwiazków stanowiacych podstawione pochodne cyklopentanu, sposób oczyszczania zwiazków stanowiacych podstawione pochodne cyklopentanu, postacie krystaliczne wspomnianych zwiazków, sposoby otrzymywania zwiazków posrednich oraz zwiazek posredni do wytwarzania zwiazków stanowiacych podstawione pochodne cyklopentanu PL213231B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14130199P 1999-06-28 1999-06-28
PCT/US2000/016013 WO2001000571A1 (en) 1999-06-28 2000-06-09 Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof

Publications (2)

Publication Number Publication Date
PL352992A1 true PL352992A1 (pl) 2003-09-22
PL213231B1 PL213231B1 (pl) 2013-01-31

Family

ID=22495095

Family Applications (1)

Application Number Title Priority Date Filing Date
PL352992A PL213231B1 (pl) 1999-06-28 2000-06-09 Sposób otrzymywania zwiazków stanowiacych podstawione pochodne cyklopentanu, sposób oczyszczania zwiazków stanowiacych podstawione pochodne cyklopentanu, postacie krystaliczne wspomnianych zwiazków, sposoby otrzymywania zwiazków posrednich oraz zwiazek posredni do wytwarzania zwiazków stanowiacych podstawione pochodne cyklopentanu

Country Status (16)

Country Link
US (1) US6576786B2 (pl)
EP (1) EP1214294A1 (pl)
JP (2) JP4262920B2 (pl)
KR (1) KR20020022727A (pl)
CN (1) CN1367776A (pl)
AR (1) AR024494A1 (pl)
AU (1) AU5732700A (pl)
BR (1) BR0011902A (pl)
CA (1) CA2377240A1 (pl)
CZ (1) CZ20014657A3 (pl)
HU (1) HUP0202097A2 (pl)
IL (1) IL147244A0 (pl)
NO (1) NO20016389L (pl)
PL (1) PL213231B1 (pl)
SK (1) SK19042001A3 (pl)
WO (1) WO2001000571A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL213231B1 (pl) * 1999-06-28 2013-01-31 Biocryst Pharmaceuticals Sposób otrzymywania zwiazków stanowiacych podstawione pochodne cyklopentanu, sposób oczyszczania zwiazków stanowiacych podstawione pochodne cyklopentanu, postacie krystaliczne wspomnianych zwiazków, sposoby otrzymywania zwiazków posrednich oraz zwiazek posredni do wytwarzania zwiazków stanowiacych podstawione pochodne cyklopentanu
WO2001062242A1 (en) * 2000-02-24 2001-08-30 Biocryst Pharmaceuticals, Inc. Prodrugs of substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
US7405336B2 (en) * 2004-10-18 2008-07-29 Fina Technology, Inc. Promoters for controlling acidity and pore size of zeolite catalysts for use in alkylation
WO2007087056A2 (en) * 2006-01-13 2007-08-02 Scolr Pharma, Inc. Peramivir derivative for oral administration
US20070203241A1 (en) 2006-02-13 2007-08-30 Babu Yarlagadda S Antiviral treatments
US20070244193A1 (en) * 2006-04-12 2007-10-18 Babu Yarlagadda S Intramuscular antiviral treatments
JP2008162935A (ja) * 2006-12-28 2008-07-17 Daicel Chem Ind Ltd アミド又はラクタムの製造法
CN101367750B (zh) 2007-08-14 2012-05-23 中国人民解放军军事医学科学院毒物药物研究所 (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途
CN102584637B (zh) * 2011-01-17 2014-07-09 天津药物研究院 帕拉米韦水合物晶体、制备方法、药用组合物及其用途
CN102757365B (zh) * 2011-04-29 2013-10-30 上海泓博智源医药技术有限公司 一种制备帕拉米韦关键中间体的方法
CN102372657B (zh) * 2011-11-14 2014-04-09 暨南大学 一种抗流感及禽流感病毒药物帕拉米韦的合成方法
CN102863359B (zh) * 2012-05-16 2014-05-07 常州制药厂有限公司 一种抗流感药物的合成方法
CN105198827A (zh) * 2015-04-13 2015-12-30 广州南新制药有限公司 一种帕拉米韦中间体的合成方法
CN108997171B (zh) * 2018-06-21 2020-11-27 苏州正济医药研究有限公司 一种3+2关环的合成方法
CN112250601B (zh) * 2020-09-08 2022-09-27 天津应天成科技有限公司 安全无毒去除帕拉米韦三水合物中间体m9中镍离子杂质的方法
CN114181117B (zh) * 2020-09-15 2023-05-05 南京正济医药研究有限公司 一种帕拉米韦中间体的制备方法
CN116425659B (zh) * 2023-03-02 2023-11-03 浙江康聚药业有限公司 一种合成帕拉米韦的方法
CN117447359B (zh) * 2023-10-26 2025-08-12 浙江诚意药业股份有限公司 一种高纯度帕拉米韦中间体的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1282316A (zh) * 1997-12-17 2001-01-31 生物晶体药品股份有限公司 用作神经氨酸酶抑制剂的取代环戊烷和环戊烯化合物
PL213231B1 (pl) * 1999-06-28 2013-01-31 Biocryst Pharmaceuticals Sposób otrzymywania zwiazków stanowiacych podstawione pochodne cyklopentanu, sposób oczyszczania zwiazków stanowiacych podstawione pochodne cyklopentanu, postacie krystaliczne wspomnianych zwiazków, sposoby otrzymywania zwiazków posrednich oraz zwiazek posredni do wytwarzania zwiazków stanowiacych podstawione pochodne cyklopentanu

Also Published As

Publication number Publication date
NO20016389D0 (no) 2001-12-27
JP4262920B2 (ja) 2009-05-13
CZ20014657A3 (cs) 2002-10-16
US20020061930A1 (en) 2002-05-23
NO20016389L (no) 2002-02-21
BR0011902A (pt) 2002-03-19
SK19042001A3 (sk) 2002-04-04
WO2001000571A1 (en) 2001-01-04
CN1367776A (zh) 2002-09-04
PL213231B1 (pl) 2013-01-31
KR20020022727A (ko) 2002-03-27
HUP0202097A2 (en) 2002-10-28
JP2003503384A (ja) 2003-01-28
EP1214294A1 (en) 2002-06-19
IL147244A0 (en) 2002-08-14
JP4597237B2 (ja) 2010-12-15
AU5732700A (en) 2001-01-31
CA2377240A1 (en) 2001-01-04
JP2009073859A (ja) 2009-04-09
AR024494A1 (es) 2002-10-02
US6576786B2 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
AU4073900A (en) A crystalline oxide-on-semiconductor structure and a generic process for preparing the structure
HUP0203206A3 (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
IL147244A0 (en) Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof
HUP0100215A3 (en) Process for the preparation of substantially amorphous alpha-ol
PL352296A1 (en) Crystalline derivatives of 1-methylocarbapeneme
EG23819A (en) Method for preparing of l-phenylephrine-hydrochloride
AU2466700A (en) Process for the preparation of urea
AU7972200A (en) Process for the preparation of urea
HUP0201531A3 (en) Dinucleotide crystals and process for preparation thereof
HUP0200003A3 (en) Tetrahydrothiopyran-o-fluorinated phenylcarbamate derivatives and process for their preparation
AU5831500A (en) Process for the preparation of polyols
AU6624000A (en) Recrystallization process
AU1037901A (en) Process for the preparation of paroxetine
IL144264A0 (en) Process for producing quinolinecarbaldehyde
GB2363605B (en) Process for the preparation of alpha-aminoketone derivatives
HUP0202865A3 (en) Process for the preparation of 2-cyanopyridines
HUP0201903A2 (en) Benzofurane derivatives and process for producing them
AU3818900A (en) Process for the preparation of substituted piperidines
IL145791A0 (en) Process for preparing mkc-442
HUP0203384A3 (en) Process for the preparation of ketimines
IL138691A (en) Process for the preparation of 3-acyl-indoles
GB2363379B (en) Process for producing alpha-aminoketones
HUP0002751A3 (en) Novel grignard-reagents and process for producing thereof
IL149527A0 (en) Process for the preparation of ketimines
HUP0004469A3 (en) Process for producing trifluormethyl-aniline derivatives